Liver Disease

Are you suffering from a Fatty Liver?

See if you are eligible to participate in a study evaluating an investigational drug for the treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH). To qualify you must:

  • be between the ages of 18 and 75
  • Have had a liver biopsy or be willing to undergo a liver biopsy

Qualified participants may receive:

  • Compensation for time and travel
  • Study-related care at no cost
  • Ask us about your liver.
    National Research Institute
    14418 Chase Street #200
    Panorama CIty, CA 91402

    Approximately 30% of these people have Fat Deposited in their Liver and Don't Know It - Ask Us About Your Liver

    Have you ever been told you have or are at risk for fat deposited in your liver?

    • Have you had abnormal lab tests?
    • Are you overweight?
    • Have you ever told you are at risk for or have diabetes?
    • Do you have a family history of liver disease related to fatty liver?

    Ask us about your liver.
    National Research Institute
    14418 Chase Street #200
    Panorama CIty, CA 91402

    A Study of HTD1801 in Adults With Nonalcoholoc Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

    This study will use an imagoing technique called LiverMultiscan to see if HTD1801 helps to treat NASH. HighTIDE Biopharma Pty. Ltd (Hightide) is the sponsor of this study.

    • Non-invasive technique, safe and painless
    • Accurately measures liver fat, as well as iron and inflammation that may indicate a level of liver disease
    • Analysis of liver to assess variations in disease condition
    • Scans completed in 15 minutes

    Ask us about your liver.
    National Research Institute
    14418 Chase Street #200
    Panorama CIty, CA 91402

    A Research Study in NonAlcoholic Steatohepatitis (NASH)

    The SEMA-NASH study (NN9931-4296) is looking at a medication called semaglutide that is being investigated for treatment of people with non-alcoholic steatohepatitis or NASH. The study involves 14 visits to the clinic and 5 telephone contacts over approximately 85 weeks. Eligible participants will receive comprehensive medical care, including regular health checks.

    You may be eligible if you:

    • are 18-75 years
    • have confirmed nonalcoholic steatohepatitis
    • able to attend clinic appointments and phone contacts throughout the study

    Are you living with Fatty Liver Disease or NASH?

    Concerned about your Fatty Liver or NASH?

    A Research Study is Enrolling Now!

    • No-cost investigational medication
    • You have a 75% chance of getting active drug
    • No-cost study-related care from a local doctor
    • You may receive compensation for your time
    • Must be between the ages of 18–75 (females must be post-menopausal or surgically sterile)
    • Must be willing to attend regular clinic visits and take oral medication


    NASH is an advanced form of fatty liver disease called non-alcoholic steato-hepatitis.

    If you have NASH you may be able to participate in this research study. If you qualify, your participation will last up to 6 years with up to 8 office visits in the first year and a half and 2 office visits every year following.

    Study drug, study-related and all study tests will be provided at no charge. Eligible participants may also be reimbursed for travel expenses.

    How's Your Liver?

    NASH is a common but often “silent” liver disease that ultimately leads to devastating consequences for many. Although similar to alcoholic liver disease, it is not caused by drinking too much alcohol.

    Read the full flyer here

    Are you overweight? Do you have diabetes, high blood pressure of high cholesterol?

    If so, you may also have FATTY LIVER DISEASE. Have a liver check-up at no cost, non-invasive, painless liver scan to understand your overall liver health.

    Free liver scan at our Panorama City Clinic from 7:30am to 2pm, Monday to Friday.

    para Español Haga clic aquí

    Have you been told that you have fatty liver or NASH?

    This is a Phase 2 clinical research study designed to examine the effect of an investigational drug in patients with fatty liver disease, more specifically patients with NASH and some evidence of liver scarring or liver fibrosis.

    To qualify you must have:

    • At least 2 of the following: Type 2 diabetes, obesity, high blood pressure, elevated liver enzymes
    • At least 18 years of age
    • NASH or non-alcoholic steatohepatitis

    If you qualify, you will receive study related:

    • Medication
    • Diagnostic procedures
    • Physical Exams
    • Laboratory tests
    • Compensation for time and travel

    Are you suffering from NASH (Nonalcoholic steatohepatitis)?

    We are looking for volunteers with biopsy-proven NASH verified by pathology reading, to evaluate the safety and efficacy of 2 oral doses of an investigational medicine in reducing liver fat.

    Qualified participants will receive at no cost:

    • Study-related medication
    • Study-related laboratory testing
    • Study-related ECGs and physical examinations
    • Physician oversight of medical care
    • Compensation for your time and travel

    Study length: Approximately 32 weeks